AAA position paper – funding augmentation therapy

A Normal Life Expectancy From Alpha-1 Proteinase Inhibitor: Methodological Considerations Related to Research on Augmentation Therapy in Alpha-1 Antitrypsin Deficiency

First announced at the 7th Alpha-1 Global Patient Congress, held at Dubrovni, Croatia, on 5 April 2019.